Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

877 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
Vasikaran S, Eastell R, Bruyère O, Foldes AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T, Wahl DA, Cooper C, Kanis JA; IOF-IFCC Bone Marker Standards Working Group. Vasikaran S, et al. Among authors: kanis ja. Osteoporos Int. 2011 Feb;22(2):391-420. doi: 10.1007/s00198-010-1501-1. Epub 2010 Dec 24. Osteoporos Int. 2011. PMID: 21184054 Review.
The effects of intravenous alendronate in Paget's disease of bone.
O'Doherty DP, McCloskey EV, Vasikaran S, Khan S, Kanis JA. O'Doherty DP, et al. Among authors: kanis ja. J Bone Miner Res. 1995 Jul;10(7):1094-100. doi: 10.1002/jbmr.5650100714. J Bone Miner Res. 1995. PMID: 7484285 Clinical Trial.
Bone densitometry in clinical practice.
Compston JE, Cooper C, Kanis JA. Compston JE, et al. Among authors: kanis ja. BMJ. 1995 Jun 10;310(6993):1507-10. doi: 10.1136/bmj.310.6993.1507. BMJ. 1995. PMID: 7787600 Free PMC article. Review. No abstract available.
How to assess drug efficacy in osteoporosis.
Cooper C, Kanis JA, Compston J. Cooper C, et al. Among authors: kanis ja. Lancet. 1995 Mar 25;345(8952):743-4. doi: 10.1016/s0140-6736(95)90635-5. Lancet. 1995. PMID: 7891482 No abstract available.
Rationale for the use of clodronate in osteoporosis.
Kanis JA, McCloskey EV, Sirtori P, Khan S, Fern D, Eyres K, Aaron J, Beneton MN. Kanis JA, et al. Osteoporos Int. 1993;3 Suppl 2:S23-8. doi: 10.1007/BF01623223. Osteoporos Int. 1993. PMID: 8481595 Review.
Evaluation of the risk of hip fracture.
Kanis JA, McCloskey EV. Kanis JA, et al. Bone. 1996 Mar;18(3 Suppl):127S-132S. doi: 10.1016/8756-3282(95)00493-9. Bone. 1996. PMID: 8777077 Review.
877 results